Common genetic variation influences the heterogeneity of response to oral glucose

Current Diabetes Reports

Volumn 10, Issue 4, 2010, Pages 249-251

  Vella, Adrian ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; INSULIN;

DIET RESTRICTION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; QUANTITATIVE TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77956392229     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-010-0119-1     Document Type: Note

References (7)

1. Stolerman ES, Florez JC: Genomics of type 2 diabetes mellitus: implications for the clinician. Nat Rev 2009, 5:429-436.
2. Dupuis J, Langenberg C, Prokopenko I, et al.: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010, 42:105-116.
3. Baggio LL, Drucker DJ: Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132:2131-2157.
4. Burcelin R, Da Costa A, Drucker D, Thorens B: Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes 2001, 50:1720-1728.
5. Bock G, Dalla Man C, Campioni M, et al.: Pathogenesis of prediabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 2006, 55:3536-3549.
6. Schafer SA, Tschritter O, Machicao F, et al.: Impaired glucagonlike peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 207, 50:2443-2450.
7. Shu L, Matveyenko AV, Kerr-Conte J, et al.: Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet 2009, 18:2388-2399.